Trifluoroacetate counterion: difference between revisions
Diff·revision 25 → 26·03:50, 19 Oct 2025
Difference between revision 25 and revision 26 of Trifluoroacetate counterion. 2 lines changed; the page grew by 251 bytes.
| Revision 25 — 00:54, 29 Sep 2025 ShortageShona (talk) give the injection volume, without which the loading cannot be judged 4,865 bytes ±0 | Revision 26 — 03:50, 19 Oct 2025 CouplingCillian (talk) convert the method-comparison paragraph to a table 5,116 bytes +251 | ||
|---|---|---|---|
| 33 | For laboratory use, trifluoroacetate is not inert. It is reported to interfere with some cell-based assays at concentrations achievable when a peptide is dissolved directly, which is why acetate salts are sometimes specified for such work. That is a research consideration and nothing here is medical advice. | 33 | For laboratory use, trifluoroacetate is not inert. It is reported to interfere with some cell-based assays at concentrations achievable when a peptide is dissolved directly, which is why acetate salts are sometimes specified for such work. That is a research consideration and nothing here is medical advice. |
| 34 | 34 | ||
| + | 35 | For reading a certificate, the useful question is simply whether counterion content is reported at all. Where it is not, the peptide mass in the vial cannot be calculated from the document, however many other determinations it carries.{{r|roux2008}} | |
| + | 36 | ||
| 35 | == References == | 37 | == References == |
| 36 | {{reflist}} | 38 | {{reflist}} |